# Xbrane Biopharma – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/xbrane-biopharma
Company JSON: https://spela.port0.org/company/xbrane-biopharma/company.json
Documents JSON: https://spela.port0.org/company/xbrane-biopharma/documents.json
Updated: 2026-08-07T08:44:50Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/xbrane-biopharma/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/xbrane-biopharma/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/xbrane-biopharma/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/xbrane-biopharma/market/instrument.json
- MFN manifest JSON: https://spela.port0.org/company/xbrane-biopharma/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/xbrane-biopharma/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/xbrane-biopharma/reports
- JSON: https://spela.port0.org/company/xbrane-biopharma/reports/reports.json
- 2026 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2026: https://view.news.eu.nasdaq.com/view?id=bf047b993615d2f514f24206cf1fed5fd&lang=sv&src=listed
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=b230a0183c7f5a68913d1d3421a036d3d&lang=sv&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=ba8507658bec6911c1b60778bf56679cf&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=b4a47b654ab5d44680744f0808f9851fe&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=b5f3e1a4e564123e3b09c684175fef78e&lang=sv&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=ba1ae222d47a4a58091d420b7012f4676&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=bd530eb5ed65bc61b69ca3ae3b699c01e&lang=sv&src=listed
- 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=b58944d561bae385c0d3ce411b2591801&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=be76eea6c6fe702a12e453aa5b0995f24&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=b4b8d3dfe9277505314f56bf7e1d47c5e&lang=sv&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=b4bcb039a935da18c889d6f11d89b3da8&lang=sv&src=listed
- 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=bbed386060026eb8c6afb9674019aee38&lang=sv&src=listed
- 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=b2fdf233b6feac2ec5383740bf8723aa3&lang=sv&src=listed
- 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=b154dada9da1be4d45f86322a1eeff6e7&lang=sv&src=listed
- 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=b2d386f2113484968b6f3832a3908579d&lang=sv&src=listed
- 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=bd15a1d16d5dd0155a56e66ae6120354a&lang=sv&src=listed
- 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=b36ceb6f7136d8f194bebbb0d3f2da048&lang=sv&src=listed

## Finansinspektionen
- Page: https://spela.port0.org/company/xbrane-biopharma/finansinspektionen
- Summary: https://spela.port0.org/company/xbrane-biopharma/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/xbrane-biopharma/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/xbrane-biopharma/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/xbrane-biopharma/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/xbrane-biopharma/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Kvartalsrapport Q2 2026: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-arsredovisning-2024/part-001.html
  - HTML part 2: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-arsredovisning-2024/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-arsredovisning-2023/part-001.html
  - HTML part 2: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-arsredovisning-2023/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/xbrane-biopharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/xbrane-biopharma/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt